German Healthcare Bill Tweak Fails to Win Over Pharma Lobby

Germany’s main pharmaceutical lobby rejected an attempt by the ruling coalition to soften the impact on the sector from its cost-cutting reform bill for the country’s public health-insurance system, according to Bloomberg.